ARTICLE | Company News
Avacta, Pall sales and marketing update
February 28, 2011 8:00 AM UTC
Avacta and Pall will co-promote Avacta's Optim 1000 ultra-low volume biopharmaceutical analysis tool in North America. Optim 1000 was developed to accelerate the speed of drug development through earl...